Non smoking for successful aging: therapeutic perspectives

Area of Science:

• Gerontology
• Public Health
• Pharmacology

Background:

• Cigarette smoking is a significant risk factor for numerous diseases, including cardiovascular, neoplastic, and respiratory conditions.
• Smoking contributes to age-related conditions like dementia, osteoporosis, diabetes, and vision impairment, reducing both life expectancy and quality of life.
• Cessation of smoking, even in elderly individuals, enhances survival rates by mitigating smoking-induced biological damage.

Purpose of the Study:

• To review the detrimental effects of smoking on aging and disease development.
• To highlight the benefits of smoking cessation for life expectancy and quality of life, particularly in older adults.
• To discuss available pharmacological and non-pharmacological strategies for smoking cessation.

Main Methods:

• Literature review of studies on smoking, aging, disease, and cessation strategies.
• Analysis of approved pharmacological treatments for smoking cessation.
• Examination of the role of motivation and combined therapy approaches.

Main Results:

• Smoking accelerates aging and increases the risk of various diseases and age-related conditions.
• Smoking cessation leads to increased survival time and improved quality of life.
• Pharmacological options include nicotine replacement therapies, bupropion, and varenicline, a selective nicotinic partial agonist.
• Varenicline effectively reduces cravings and withdrawal symptoms.
• Combined pharmacotherapy and behavioral/cognitive counseling yield the highest abstinence rates.

Conclusions:

• Smoking cessation is crucial for improving health outcomes and quality of life, especially in the elderly.
• A combination of pharmacotherapy and behavioral support is the most effective approach for successful smoking cessation.
• Motivation remains a key factor for successful smoking cessation.